Filing Details

Accession Number:
0001209191-13-058265
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-20 17:32:26
Reporting Period:
2013-12-18
Filing Date:
2013-12-20
Accepted Time:
2013-12-20 17:32:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
858803 Avanir Pharmaceuticals Inc. AVNR Pharmaceutical Preparations (2834) 330314804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534986 Md Joao Siffert 20 Enterprise,
Suite 200
Aliso Viejo CA 92656
Svp, R&d No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-18 5,970 $2.63 110,230 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The proceeds from the sales will be used to pay required withholdings due by the Reporting Person upon the vesting of 12,282 Restricted Stock Units on December 17, 2013. Following the sales reported on this Form 4, the Reporting Person has a total of 172,031 options to purchase shares of common stock that are vested and immediately exercisable and a total of 245,625 options to purchase shares of common stock that have not yet vested. Following the sales reported on this Form 4, the Reporting Person also has 214,225 unvested Restricted Stock Units, of which 43,000 are performance-based Restricted Stock Units.
  2. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.